PRN1008 (Rilzabrutinib) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.3 nM.
[1] Smith PF, et al. 2017 Nov;83(11):2367-2376.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1mg | ¥573.00 | 现货 | 1 | |
| 5mg | ¥1,386.00 | 现货 | 1 | |
| 10mg | ¥2,289.00 | 现货 | 1 | |
| 25mg | ¥3,661.00 | 现货 | 1 | |
| 50mg | ¥5,033.00 | 现货 | 1 | |
| 100mg | ¥6,776.00 | 现货 | 1 | |
| 200mg | ¥8,960.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥2,079.00 | 现货 | 1 |
















PRN1008 (Rilzabrutinib) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.3 nM.
[1] Smith PF, et al. 2017 Nov;83(11):2367-2376.